GlaxoSmithKline Sues Moderna for Patent Infringement Over COVID Vaccines
Insurance Journal - Oct 15, 2024
British drugmaker GlaxoSmithKline sued Moderna in federal court in Delaware on Tuesday, accusing its American rival of violating GSK’s patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax. According to the two lawsuits, Moderna’s lipid nanoparti...
Recommended Articles
Posted: Nov 03, 2025
Encova Insurance, headquartered in Columbus, Ohio, named Zach Webber as vice president, corporate ac...
Posted: Nov 03, 2025
Spend enough time along the shores of Lake Superior and it won’t be long before there’s...
Posted: Nov 03, 2025
ReSource Pro, a strategic operations partner serving the insurance industry, announced the acquisiti...